Entero Healthcare Solutions Limited

Entero Healthcare Solutions Limited (ENTERO) is a small-cap Consumer Services company valued at ₹6,943 crore operating in Pharmacy Retail on the NSE and BSE.

Recent price move

Entero Healthcare Solutions Limited last traded at ₹1,577.3, modestly down 0.24% on the day.

Recent developments

On 2026-06-30, the company reported its latest quarterly results, showing strong revenue and net profit growth. Promoter holding remained at 52.40%, while foreign institutional holding increased by 0.34 percentage points and domestic institutional holding decreased by 1.14 percentage points.

Financial performance

The company's business is improving, with annual revenue rising 29.3% and net profit growing 36.3% year-over-year. The latest quarter saw revenue jump 38.2% and net profit surge 73.5% compared to the same quarter a year earlier, with net profit margin expanding 0.1 percentage points to 2.2%.

Valuation multiples

The stock trades at 59.7 times earnings, 4.65 times book value.

Things to watch

The company has not paid any dividends despite reporting profits. Its return on equity is 6.8%, which is relatively low, and its return on capital employed is 10.2%, indicating limited profitability relative to capital used. The stock is 12.5% below its 52-week high.

Where it stands

The company has shown strong revenue and profit growth in both annual and quarterly terms, with net profit margin improving. The stock is currently 12.5% below its 52-week high, and the company has not distributed any dividends to shareholders.

Summarised by DocStoX's model on 2026-10-03 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.